Home > Drug Search >
  • company_query: ANI Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (10) biology (16)
Status:
Approved (1) Phase Ⅲ (4) Phase Ⅱ (15) Phase Ⅰ (6)
Clinical Stage:
Pending (5) Active (14) Discontinued (6)
Bio-Type:
Gene therapy (4) Cell therapy (1) Oncolytic virus (1) Recombinant coagulation factor (1) Recombinant cytokines (2) Recombinant hormone (1) Bispecific antibody (1)
Indication:
Acne (1) Acute coronary syndrome (ACS) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Anemia (1) Bladder cancer (1) Varicose veins (1) Coronary artery disease (CAD) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Endometrial cancer (1) Hypercholesterolemia (1) Hyperlipidemia (1) Hypertension (1) Leukemia (1) Major depressive disorder (MDD) (1) Melanoma (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Obesity (1) Ovarian cancer (1) Pancreatic cancer (2) Postoperative pain (2) Prostate cancer (2) Solid tumours (1) Type 2 diabetes (2) Oesophageal varices (1) Type 1 diabetes (1) Hemophilia A (1) Hemophilia B (1) Neutropenia (1) Coronary restenosis (1) Central nervous system disorders (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top